JUDITH SCHAETZER: Open Payments
NPI 1043963689 · PUNTA GORDA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,926 in 63 payments from 13 companies in 2025. Trend: 2023 $1,601 · 2024 $1,593 · 2025 $1,926
Food & beverage: $1,926
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $360 |
| ABBVIE INC. | 5 | $283 |
| Axsome Therapeutics, Inc. | 6 | $239 |
| E.R. Squibb & Sons, L.L.C. | 7 | $237 |
| Janssen Pharmaceuticals, Inc | 3 | $219 |
| Alkermes, Inc. | 12 | $213 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $144 |
| Vanda Pharmaceuticals Inc. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Indivior Inc. | 2 | $40 |
Products named: INGREZZA, VRAYLAR, Auvelity, COBENFY, INVEGA SUSTENNA, ARISTADA, CAPLYTA, FANAPT.
Industry payments across FL — which companies pay providers there.
